BELLUCCI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 3.477
EU - Europa 2.855
AS - Asia 580
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.930
Nazione #
US - Stati Uniti d'America 3.471
PL - Polonia 926
RU - Federazione Russa 728
SE - Svezia 283
IE - Irlanda 277
IT - Italia 233
HK - Hong Kong 146
SG - Singapore 131
VN - Vietnam 124
UA - Ucraina 117
CN - Cina 105
DE - Germania 100
FI - Finlandia 73
GB - Regno Unito 61
IN - India 54
FR - Francia 12
BE - Belgio 11
CI - Costa d'Avorio 11
JO - Giordania 10
CH - Svizzera 9
ES - Italia 7
CA - Canada 6
NL - Olanda 6
RO - Romania 6
SC - Seychelles 5
TR - Turchia 5
HR - Croazia 4
KR - Corea 2
AT - Austria 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
NG - Nigeria 1
Totale 6.930
Città #
Warsaw 924
Ashburn 437
Santa Clara 421
Fairfield 321
Chandler 301
Dublin 277
Woodbridge 190
Jacksonville 171
Cambridge 155
Seattle 153
Houston 143
Wilmington 131
Dong Ket 124
Singapore 102
Hong Kong 92
Ann Arbor 91
Princeton 69
Boston 59
Altamura 54
Mumbai 50
Lawrence 41
Boardman 40
Buffalo 37
Florence 37
Beijing 28
Falls Church 20
Medford 20
Shanghai 20
Norwalk 17
Guangzhou 15
Moscow 15
Kent 14
Washington 14
San Diego 13
Los Angeles 12
West Jordan 12
Abidjan 11
Brussels 11
Dearborn 10
Bern 9
Hillsboro 9
Milan 9
Helsinki 8
Philadelphia 8
Rome 8
Verona 8
Barcelona 7
Yubileyny 7
Andover 6
Frankfurt Am Main 6
Lappeenranta 5
Munich 5
Phoenix 5
Redwood City 5
Toronto 5
Auburn Hills 4
Düsseldorf 4
Genoa 4
Izmir 4
New York 4
Amherst 3
Laurel 3
Nuremberg 3
San Martino Buon Albergo 3
Sassano 3
Arezzo 2
Ascoli Piceno 2
Castelfranco Emilia 2
Cedar Knolls 2
Gavirate 2
Groningen 2
Kensington 2
Krakow 2
Monza 2
Parma 2
Pesaro 2
Redmond 2
Teggiano 2
Trumbull 2
Venezia 2
Vercelli 2
Aalen 1
Amsterdam 1
Bari 1
Bend 1
Bologna 1
Bremen 1
Budapest 1
Catanzaro 1
Cetraro 1
Chestnut Hill 1
Dallas 1
Duncan 1
Edinburgh 1
Fabro 1
Fisciano 1
Gottolengo 1
Grevenbroich 1
Haifa 1
Hangzhou 1
Totale 4.848
Nome #
Antinociceptive property of the nicotinic agonist AG4 in rodents 455
Antisense knockdowns of M1 receptors induces transient anterograde amnesia in mice 260
Memory facilitation with atropine: a paradoxical effect 242
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 240
In vitro characterization of a novel, potent and selective M3 antagonist 231
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 220
Antinociceptive and antiamnesic properties of the presynaptic amplifier PG-9 205
MOLECULAR MODULATION OF MUSCARINIC ANTAGONISTS. SYNTHESIS AND AFFINITY PROFILE OF 2,2-DIPHENYL-2-ETHYLTHIO-ACETIC ACID ESTERS DESIGNED TO PROBE THE BINDING SITE CAVITY 169
Multidrug resistance (MDR) reversers: High activity and efficacy in a series of asymmetrical N,N-bis(alkanol)amine aryl esters 154
Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist. 137
Antagonisti muscarinici a struttura 1,3-ossatiolano-2-pirrolidinica 134
Synthesis and Cholinergic Affinity of Diastereomeric and Enantiomeric Isomers of 1-Methyl-2-(2-methyl-1,3-dioxolan-4-yl)-pyrrolidine, 1-Methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine and of Their Iodomethylates 134
SYNTHESIS, AFFINITY PROFILE AND FUNCTIONAL ACTIVITY OF MUSCARINIC ANTAGONISTS WITH A 1-METHYL-2-(2,2-ALKYLARYL-1,3-OXATHIOLAN-5-YL)PYRROLIDINE STRUCTURE 132
FURTHER STRUCTURE-ACTIVITY RELATIONSHIPS IN THE SERIES OF TROPANYL ESTERS ENDOWED WITH POTENT ANTINOCICEPTIVE ACTIVITY 131
New structure–activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR) 130
(1,3-Dioxolane)- and (1,3-oxathiolane)-2-pyrrolidines: molecular hybrids with potential anti-Alzheimer activity 129
Carbachol dimers as homobivalent modulators of muscarinic receptors 122
1,4-Diazabicyclo[4.3.0]nonan-9-ones and 1,4-diamidopiperazines as new classes of highly potent nootropic drugs 119
DIFFERENTIAL ANALGESIC ACTIVITY OF THE ENANTIOMERS OF ATROPINE DERIVATIVES DOES NOT CORRELATE WITH THEIR MUSCARINIC SUBTYPE SELECTIVITY 118
1,4-Diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs 116
Muscarinic antagonists with multiple stereocenters: synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivatives 112
Muscarinic subtype affinity and functional activity profile of 1-methyl-2-(2-methyl-1,3-dioxolan-4-yl)pyrrolidine and 1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine derivatives. 111
SYNTHESIS, CHARACTERIZATION AND PHARMACOLOGICAL PROFILE OF TROPICAMIDE ENANTIOMERS 110
Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities 108
ANALGESIC, ANTIMUSCARINIC ACTIVITY AND ENANTIOSELECTIVITY OF THE FOUR ISOMERS OF 3-QUINUCLIDINYL TROPATE AS COMPARED WITH THE ENANTIOMERS OF HYOSCYAMINE 103
NEGATIVE INOTROPIC ACTIVITY OF PARA-SUBSTITUTED DIETHYL BENZYL PHOSPHONATES RELATED TO FOSTEDIL 103
Structure-activity relationships in 2,2-diphenyl-2-ethylthioacetic acid esters: unexpected agonistic activity in a series of muscarinic antagonists. 102
Muscarine-like compounds derived from a pyrolysis product of cellulose 102
Design, synthesis and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain 100
New insights in the metabolism of Oxybutynin: evidence of N-oxidation of propargylamine moiety and rearrangement to enaminoketone 99
MOLECULAR MODULATION OF MUSCARINIC ANTAGONISTS. SYNTHESIS AND PHARMACOLOGICAL PROFILE OF 2,2-DIPHENYL-2-ETHYLTHIOACETIC AND 3,3-DIPHENYL-3-ETHYLTHIOPROPIONIC ACID DERIVATIVES CHARACTERIZED BY A DIPEPTIDE SPACER 98
New quinoline derivatives as nicotinic receptor modulators 95
Synthesis, Affinity Profile and Functional Activity of Potent Chiral Muscarinic Antagonists with a Pyrrolidinylfuran Structure 94
Synthesis and pharmacological characterization of chiral pyrrolidinylfuran derivatives: the discovery of new functionally selective muscarinic agonists 93
Attività analgesica e antimuscarinica ed enantioselettività dei quattro isomeri del tropato del 3-chinuclidinolo messe a confronto con gli enantiomeri della iosciamina 93
Differential analgesic activity of the enantiomers of atropine derivatives does not correlate with their muscarinic subtype selectivity 91
New Rigid Nicotine Analogues, Carrying a Norbornane Moiety, Are Potent Agonists of α7 and α3∗ Nicotinic Receptors 88
Carbachol dimers with primary carbamate groups as homobivalent modulators of muscarinic receptors 85
Modulazione molecolare di antagonisti muscarinici. Sintesi e valutazione farmacologica preliminare di esteri amminoalchil piperazinici e piperidinici dell'acido 2,2-difenil-2-etiltioacetico 83
synthesis, chiral HPLC separation and pharmacological characterization of muscarinic furan derivatives 82
NEGATIVE INOTROPIC AND CALCIUM ANTAGONISTIC ACTIVITY OF ALKYL AND ARYLALKYL PHOSPHONATES 78
Highly chiral muscarinic ligands: synthesis and affinity of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-oxathiolane-5-yl)pyrrolidine 3-sulfoxides and their methyl iodides 71
Sintesi e valutazione farmacologica di derivati furanici e tetraidrofuranici a potenziale azione muscarinica 70
New multidrug resistance (MDR) agents endowed with good potency and efficacy 70
Sintesi e affinità per i recettori colinergici degli stereoisomeri della 1-metil-2-(2-metil-1,3-diossolan-4-il)pirrolidina, della 1-metil-2-(2-metil-1,3-ossatiolan-5-il)pirrolidina e dei loro iodometilati 69
SAR STUDIES IN THE FIELD OF CA2+ ANTAGONISTS. EFFECT OF MODIFICATIONS AT THE TETRASUBSTITUTED CARBON OF VERAPAMIL-LIKE COMPOUNDS 66
Flavonoid aminoesters acting as reversing agents of Pgp-dependent multidrug resistance (MDR) 65
Design, Synthesis and binding affinity of new ligands for the central nicotinic receptors 64
New N-alkanol-N-cyclohexanolamine aryl ester derivatives as reverting agents of Multidrug Resistance (MDR) 61
SEARCH FOR NEW CA2+ ANTAGONISTS. LIPOPHILIC OXIMES AND PHOSPHONATES 60
Hybridized and isosteric analogs of N1-acetyl-N4-dimethyl-piperazinium iodide (ADMP) and N1-phenyl-N4-dimethyl-piperazinium iodide (DMPP) with central nicotinic action 60
Design, Synthesis and binding affinity of carbachol dimers as bitopic ligands 60
Molecular modulation of muscarinic antagonists. Synthesis and pharmacological profile of 2,2-diphenyl-2-ethylthioacetic acid and 3,3-diphenyl-3-ethylthiopropionic acid derivatives characterized by a dipeptide spacer 60
New potent piperazine and aminopiperidine derivatives as reverting agents of Multidrug Resistance (MDR) 59
Synthesis and pharmacological characterization of diastereomeric and enantiomeric isomers of 1-methyl-2-(2-methyl-1,3-oxathiolane-5-yl)pyrrolidine 3-sulfoxides and their methyl iodides 58
New analogues of the potent nootropic drug DM235: 2-or 3-phenylpiperazines with limited conformational flexibility 57
Design, synthesis and preliminary pharmacological evaluation of alkylderivatives of 4-aminopiperidine as N-type calcium channels blockers 57
Unexpected agonistic activity in a series of muscarinic antagonists 53
Antinociceptive and antiamnesic properties of the nicotinic agonist AG-4 52
Piperazine derivatives possessing nootropic activity 50
Unexpected Multidrug Resistance (MDR) reverting activity of a new series of N,N-bis(arylalkanol)amine aryl esters 46
Hybridized and isosteric analogs of N1-acetyl-N4-dimethylpiperazinium iodide (ADMP), N1-phenyl-N4-dimethylpiperazinium iodide (DMPP) with central nicotinic action 42
The double life of UNIFI nootropics 40
Hybridized and isosteric analogs of N1-acetyl-N4-dimethylpiperazinium iodide (ADMP), N1-phenyl-N4-dimethylpiperazinium iodide (DMPP) with central nicotinic action 38
Progettazione, Sintesi e studio di molecular modeling di nuovi ligandi nicotinici 36
Pharmacological profile of the enantiomers of tropicamide 32
Totale 7.004
Categoria #
all - tutte 17.423
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.423


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020696 0 0 0 0 109 119 98 120 85 56 88 21
2020/2021801 52 53 46 88 21 93 35 56 56 99 33 169
2021/2022441 15 69 18 13 16 19 28 12 15 18 87 131
2022/20231.201 113 180 53 96 84 232 170 72 127 12 42 20
2023/2024651 8 50 76 31 24 60 17 315 7 23 17 23
2024/20251.573 99 291 192 413 578 0 0 0 0 0 0 0
Totale 7.004